• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

更新肥胖和胆固醇在乳腺癌中的作用。

Updating the role of obesity and cholesterol in breast cancer.

机构信息

Breast Cancer Department, MD Anderson Cancer Center, Arturo Soria 270, 280339, Madrid, Spain.

Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPaz, & Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

出版信息

Breast Cancer Res. 2019 Mar 1;21(1):35. doi: 10.1186/s13058-019-1124-1.

DOI:10.1186/s13058-019-1124-1
PMID:30823902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6397485/
Abstract

BACKGROUND

Breast cancer is the second most common cause of cancer-related death among women. Advances in our understanding of the disease have translated into better diagnostics and more effective therapeutics, leading to earlier detection and improved outcomes. Several studies have pointed at lifestyle and environmental factors as contributory for the onset and progression of the disease. Obesity and cholesterol stand out for their potential causal relationship with breast cancer and ease of modification.

MAIN TEXT

Obesity and cholesterol represent risk factors for breast cancer, but their impact is largely affected by cofounding variables including menopausal status, disease subtype, and inflammation. Establishing a causal relationship between lifestyle factors and clinical outcomes may be challenging. Epidemiological studies and meta-analyses have rendered conflicting or sometimes contradictory results, possibly owing to the multifactorial nature of the disease. We discuss the supporting evidence and limitations in our understanding of obesity and cholesterol as risk factors for breast cancer.

CONCLUSIONS

There is sufficient evidence that obesity and cholesterol impact clinical outcomes. Physicians are advised to take steps to help patients with their weight, such as recommending dietary and lifestyle interventions.

摘要

背景

乳腺癌是女性癌症相关死亡的第二大常见原因。我们对该疾病的认识的进步已经转化为更好的诊断和更有效的治疗方法,从而实现了更早的检测和更好的结果。有几项研究指出,生活方式和环境因素是导致疾病发生和进展的因素。肥胖和胆固醇因其与乳腺癌的潜在因果关系以及易于改变而引人注目。

正文

肥胖和胆固醇是乳腺癌的危险因素,但它们的影响在很大程度上受到混杂变量的影响,包括绝经状态、疾病亚型和炎症。在生活方式因素与临床结果之间建立因果关系可能具有挑战性。流行病学研究和荟萃分析得出的结果相互矛盾,有时甚至相互矛盾,这可能是由于该疾病的多因素性质所致。我们讨论了肥胖和胆固醇作为乳腺癌危险因素的支持证据和理解上的局限性。

结论

有足够的证据表明肥胖和胆固醇会影响临床结果。建议医生采取措施帮助患者控制体重,例如推荐饮食和生活方式干预。

相似文献

1
Updating the role of obesity and cholesterol in breast cancer.更新肥胖和胆固醇在乳腺癌中的作用。
Breast Cancer Res. 2019 Mar 1;21(1):35. doi: 10.1186/s13058-019-1124-1.
2
Obesity and prognosis of breast cancer.肥胖与乳腺癌的预后
Obes Rev. 2006 Nov;7(4):333-40. doi: 10.1111/j.1467-789X.2006.00261.x.
3
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.血清高密度脂蛋白胆固醇、代谢谱与乳腺癌风险。
J Natl Cancer Inst. 2004 Aug 4;96(15):1152-60. doi: 10.1093/jnci/djh216.
4
Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.体质指数和腰臀比联合雌孕激素受体状态对中国北方和东部地区乳腺癌发病风险的影响:病例对照研究结果及其对化学预防的意义。
Oncologist. 2017 Dec;22(12):1431-1443. doi: 10.1634/theoncologist.2017-0148. Epub 2017 Sep 14.
5
Potential effects of nutrition-based weight loss therapies in reversing obesity-related breast cancer epigenetic marks.基于营养的减肥疗法对逆转肥胖相关乳腺癌表观遗传标记的潜在影响。
Food Funct. 2021 Feb 21;12(4):1402-1414. doi: 10.1039/d0fo01984d. Epub 2021 Jan 22.
6
Association of lifestyle and other risk factors with breast cancer according to menopausal status: a case-control study in the Region of Western Pomerania (Poland).根据绝经状态分析生活方式及其他风险因素与乳腺癌的关联:在波兰西波美拉尼亚地区开展的一项病例对照研究
Asian Pac J Cancer Prev. 2007 Oct-Dec;8(4):513-24.
7
The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer.雌激素受体作为胆固醇在乳腺癌中病理作用的介质。
Climacteric. 2014 Dec;17 Suppl 2(0 2):60-5. doi: 10.3109/13697137.2014.966949. Epub 2014 Oct 16.
8
Studies on how lifestyle factors may affect breast cancer risk and recurrence.关于生活方式因素如何影响乳腺癌风险和复发的研究。
J Natl Cancer Inst. 2012 Apr 18;104(8):574-6. doi: 10.1093/jnci/djs213. Epub 2012 Apr 3.
9
The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.包含饮食成分的体重管理干预措施对孕妇和产后女性体重相关结局的影响:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):88-98. doi: 10.11124/jbisrir-2015-1812.
10
Breast cancer risk in the WHI study: the problem of obesity.妇女健康倡议研究中的乳腺癌风险:肥胖问题
Maturitas. 2005 May 16;51(1):83-97. doi: 10.1016/j.maturitas.2005.02.018.

引用本文的文献

1
EMC2 promotes triple negative breast cancer growth by protecting FDFT1 from endoplasmic reticulum associated degradation to impair ferroptosis susceptibility.EMC2通过保护FDFT1免受内质网相关降解以削弱铁死亡易感性来促进三阴性乳腺癌生长。
Oncogene. 2025 Sep 10. doi: 10.1038/s41388-025-03545-3.
2
ANTHROPOLOGICAL ASPECTS OF THE BODY MASS INDEX IN BREAST CANCER.乳腺癌患者体重指数的人类学方面
Acta Endocrinol (Buchar). 2024 Jul-Sep;20(3):286-294. doi: 10.4183/aeb.2024.286. Epub 2025 May 23.
3
Causal relationships between four types of lipids and breast cancer risk with potential mediators: evidence from Mendelian randomization study and bioinformatics analysis.

本文引用的文献

1
Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort.循环 27-羟胆固醇与乳腺癌风险:EPIC-Heidelberg 队列研究结果。
J Natl Cancer Inst. 2019 Apr 1;111(4):365-371. doi: 10.1093/jnci/djy115.
2
Statins: a role in breast cancer therapy?他汀类药物:在乳腺癌治疗中的作用?
J Intern Med. 2018 Oct;284(4):346-357. doi: 10.1111/joim.12806. Epub 2018 Jul 9.
3
Association between obesity with disease-free survival and overall survival in triple-negative breast cancer: A meta-analysis.
四种脂质与乳腺癌风险之间的因果关系及潜在中介因素:孟德尔随机化研究和生物信息学分析的证据
Discov Oncol. 2025 May 16;16(1):791. doi: 10.1007/s12672-025-02597-x.
4
Proteomic and lipidomic analysis of low-density lipoprotein identifies potential biomarkers of early estrogen receptor-positive breast cancer.低密度脂蛋白的蛋白质组学和脂质组学分析确定了早期雌激素受体阳性乳腺癌的潜在生物标志物。
Cancer Metab. 2025 May 1;13(1):20. doi: 10.1186/s40170-025-00390-6.
5
A lipid metabolism related gene signature predicts postoperative recurrence in pancreatic cancer through multicenter cohort validation.一种与脂质代谢相关的基因特征通过多中心队列验证预测胰腺癌术后复发。
Sci Rep. 2025 Apr 5;15(1):11683. doi: 10.1038/s41598-025-96855-1.
6
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment.脂质代谢重编程:乳腺癌进展和肿瘤微环境中被忽视的英雄。
Mol Cancer. 2025 Mar 3;24(1):61. doi: 10.1186/s12943-025-02258-1.
7
Predicting doxorubicin-induced cardiotoxicity in breast cancer: leveraging machine learning with synthetic data.预测乳腺癌中阿霉素诱导的心脏毒性:利用机器学习与合成数据
Med Biol Eng Comput. 2025 May;63(5):1535-1550. doi: 10.1007/s11517-025-03289-y. Epub 2025 Jan 20.
8
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor.一种常见的遗传性人类前蛋白转化酶枯草溶菌素9(PCSK9)种系变体通过低密度脂蛋白受体相关蛋白1(LRP1)受体驱动乳腺癌转移。
Cell. 2025 Jan 23;188(2):371-389.e28. doi: 10.1016/j.cell.2024.11.009. Epub 2024 Dec 9.
9
Breast cancer and its determinants in Ethiopia: a systematic review and meta-analysis.乳腺癌及其在埃塞俄比亚的决定因素:系统评价和荟萃分析。
BMJ Open. 2024 Nov 2;14(11):e080080. doi: 10.1136/bmjopen-2023-080080.
10
Anticancer Potential of Flavonoids: Their Role in Cancer Prevention and Health Benefits.类黄酮的抗癌潜力:它们在癌症预防中的作用及健康益处。
Foods. 2024 Jul 17;13(14):2253. doi: 10.3390/foods13142253.
肥胖与三阴性乳腺癌无病生存期和总生存期之间的关联:一项荟萃分析。
Medicine (Baltimore). 2018 May;97(19):e0719. doi: 10.1097/MD.0000000000010719.
4
Adherence to Mediterranean Diet and Risk of Cancer: An Updated Systematic Review and Meta-Analysis.坚持地中海饮食与癌症风险:更新的系统性回顾和荟萃分析。
Nutrients. 2017 Sep 26;9(10):1063. doi: 10.3390/nu9101063.
5
Exploring association between statin use and breast cancer risk: an updated meta-analysis.探索他汀类药物使用与乳腺癌风险之间的关联:一项更新的荟萃分析。
Arch Gynecol Obstet. 2017 Dec;296(6):1043-1053. doi: 10.1007/s00404-017-4533-3. Epub 2017 Sep 22.
6
The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer.胆固醇及其代谢产物 27-羟胆固醇在乳腺癌中的意义。
Mol Cell Endocrinol. 2018 May 5;466:73-80. doi: 10.1016/j.mce.2017.09.021. Epub 2017 Sep 15.
7
Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence.体力活动、久坐行为、饮食与癌症:最新情况及新出现的证据
Lancet Oncol. 2017 Aug;18(8):e457-e471. doi: 10.1016/S1470-2045(17)30411-4. Epub 2017 Jul 26.
8
Serum antioxidant capacity, biochemical profile and body composition of breast cancer survivors in a randomized Mediterranean dietary intervention study.随机地中海饮食干预研究中乳腺癌幸存者的血清抗氧化能力、生化特征和身体成分。
Eur J Nutr. 2018 Sep;57(6):2133-2145. doi: 10.1007/s00394-017-1489-9. Epub 2017 Jun 20.
9
Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer.27-羟化酶(CYP27A1)和27-羟胆固醇在乳腺癌中的作用
Endocr Relat Cancer. 2017 Jul;24(7):339-349. doi: 10.1530/ERC-16-0533. Epub 2017 Apr 25.
10
Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.在 BIG 1-98 研究中胆固醇、降胆固醇药物的使用与乳腺癌结局的关系。
J Clin Oncol. 2017 Apr 10;35(11):1179-1188. doi: 10.1200/JCO.2016.70.3116. Epub 2017 Feb 13.